Fundz

Bio Gene Therapeutics reported raising $250,000 in an initial SEC Form D filing, from an offering of $250,000

PRIVATEAug 06, 2026Late filing, first sale Aug 18, 2025

Amount Raised

$250,000

$250,000 sold, per SEC Form D (first sale Aug 18, 2025)

Round Type

Venture

AustinBiotechnologyHealth Care

Quick answer

BioGene Therapeutics raised $250,000 in a funding round, dated August 18, 2025. BioGene Therapeutics is based in Austin, Texas, United States.

How much did BioGene Therapeutics raise?
BioGene Therapeutics raised $250,000 in a funding round on August 18, 2025.
What does BioGene Therapeutics do?
BioGene Therapeutics Inc. ("BioGene") is a Texas-based life sciences company focused on advancing innovative therapies in metabolic health and gene-based treatments.
Where is BioGene Therapeutics based and how big is it?
BioGene Therapeutics is based in Austin, Texas, United States. Fundz records about 5 employees.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as BioGene Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Psilera raised $1.5M (Grant) on October 2, 2025.
  • Motor City Dental Partners raised an undisclosed amount (Debt Financing) on October 2, 2025.
  • Kihealth raised $5M (Seed) on October 2, 2025.
  • QuantHealth raised an undisclosed amount (Corporate Round) on October 1, 2025.
  • Athernal Bio raised $4.7M (Funding Round) on October 1, 2025.
  • Aerska raised $21M (Seed) on October 1, 2025.

Who to call at BioGene Therapeutics, and when

A new round usually means BioGene Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day BioGene Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BioGene Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BioGene Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

BioGene Therapeutics

Location

Austin, Texas, United States

About

BioGene Therapeutics Inc. ("BioGene") is a Texas-based life sciences company focused on advancing innovative therapies in metabolic health and gene-based treatments. As a key component of BioGene's expansion, BioGene Australia operates as a wholly-owned subsidiary of BioGene in Texas, leveraging the strategic benefits of Australia's 43.5% R&D tax cashback incentive. This subsidiary supports ongoing research and development activities in Australia, where BioGene capitalizes on exceptional scientific talent and the nation's commitment to advancing life sciences. Currently, BioGene Australia is engaged in pioneering research advancing gene therapy-based approaches designed to address the growing global diabetes and obesity crisis.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment BioGene Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for BioGene Therapeutics's next move

See what Strategic adds

BioGene Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.